These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10334766)

  • 41. Homeostatic effect of laughter on diabetic cardiovascular complications: The myth turned to fact.
    Noureldein MH; Eid AA
    Diabetes Res Clin Pract; 2018 Jan; 135():111-119. PubMed ID: 29162513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardiovascular trials in diabetes: past and present. Invited lecture of the XXXVth National Congress of the Spanish Society of Cardiology].
    Pyörälä K
    Rev Esp Cardiol; 2000 Dec; 53(12):1553-60. PubMed ID: 11171476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypertension and diabetes.
    Sowers JR; Levy J; Zemel MB
    Med Clin North Am; 1988 Nov; 72(6):1399-414. PubMed ID: 3054360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The pancreatic heart].
    Cananau S; Uebersax R
    Rev Med Suisse Romande; 1995 Sep; 115(9):693-705. PubMed ID: 7481357
    [No Abstract]   [Full Text] [Related]  

  • 46. Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies.
    Menotti A; Lanti M; Agabiti-Rosei E; Carratelli L; Cavera G; Dormi A; Gaddi A; Mancini M; Motolese M; Muiesan ML; Muntoni S; Muntoni S; Notarbartolo A; Prati P; Remiddi S; Zanchetti A
    Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):426-40. PubMed ID: 16314229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diabetes and its cardiovascular complications. Research acquisitions in Malta].
    Zammit Maempel JV
    Minerva Med; 1972 May; 63(39):2229-36. PubMed ID: 5035393
    [No Abstract]   [Full Text] [Related]  

  • 48. Obesity, diabetes, and risk of cardiovascular disease in the elderly.
    Wilson PW; Kannel WB
    Am J Geriatr Cardiol; 2002; 11(2):119-23,125. PubMed ID: 11872970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deep Personal Multitask Prediction of Diabetes Complication with Attentive Interactions Predicting Diabetes Complications by Multitask-Learning.
    Zuo M; Zhang W; Xu Q; Chen D
    J Healthc Eng; 2022; 2022():5129125. PubMed ID: 35494508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors other than hyperglycemia in diabetic macrovascular disease.
    Medalie JH
    Diabetes Care; 1979; 2(2):77-84. PubMed ID: 520133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiology patient pages. Cardiovascular disease in the diabetic patient.
    Goldfine AB; Goldfine HL
    Circulation; 2003 Jan; 107(2):e14-6. PubMed ID: 12538441
    [No Abstract]   [Full Text] [Related]  

  • 52. [On diabetic vascular complications. (Remarks on the diagnosis, prognosis and therapy of vasopathies in diabetics)].
    KINK R
    Munch Med Wochenschr; 1962 Mar; 104():442-6. PubMed ID: 14456158
    [No Abstract]   [Full Text] [Related]  

  • 53. [Improvement in glycemic control, cardiovascular risk factors and anthropometric data in type 2 diabetic patients after the switch from biphasic human insulin to biphasic premix analog insulin aspart].
    Gero L; Gyimesi A; Hidvégi T; Jánosi I
    Orv Hetil; 2009 Aug; 150(35):1637-47. PubMed ID: 19692308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes.
    Phumipamorn S; Pongwecharak J; Soorapan S; Pattharachayakul S
    Prim Care Diabetes; 2008 Feb; 2(1):31-7. PubMed ID: 18684418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience.
    Kannel WB; D'Agostino RB; Wilson PW; Belanger AJ; Gagnon DR
    Am Heart J; 1990 Sep; 120(3):672-6. PubMed ID: 2389702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular disease in a diabetic clinic.
    LEWIS JG; SYMONS C
    Lancet; 1958 Nov; 2(7054):985-8. PubMed ID: 13599457
    [No Abstract]   [Full Text] [Related]  

  • 57. A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension.
    Basile JN; Lackland DT; Basile JM; Riehle JE; Egan BM
    J Clin Hypertens (Greenwich); 2004 Jan; 6(1):18-25. PubMed ID: 14724420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vascular changes in diabetic patients].
    LISIECKA-ADAMSKA H; ADAMSKI S
    Pol Arch Med Wewn; 1958; 28(5):842-4. PubMed ID: 13601347
    [No Abstract]   [Full Text] [Related]  

  • 59. [Aterial hypertension and cardiovascular risk factors associated with diabetes. Report of the PHARE survey in general practice].
    Chamontin B; Lang T; Vaisse B; Nicodeme R; Antoine MP; Lazorthes ML; Gallois H; Poggi L
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):869-73. PubMed ID: 11575221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular risk factors in newly diagnosed abnormal glucose tolerance: comparison of 1997 ADA and 1985 WHO criteria.
    Rathmann W; Giani G; Mielck A
    Diabetologia; 1999 Oct; 42(10):1268-9. PubMed ID: 10525673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.